Staff turnover in EUR588.471531.273538.931550.978534.887
Staff turnover in EUR588.471531.273538.931550.978534.887
Die Aktie: Angaben in EURO20212022202320242025
Aktien im Umlauf (in Mio.)3,003,003,00262,613,00
Dividende pro Aktie0.561.121.121.120.34
unverwässertes Ergebnis pro Aktie5,313,593,993,330,72
GuV in Mio. EURO nach IAS/IFRS20212022202320242025
Umsatz6.360,06.174,06.263,06.403,06.216,0
Operatives Ergebnis (EBIT)1.537,71.328,61.032,61.149,6808,0
Ergebnis vor Steuer (EBT)1.529,01.122,0673,0807,0425,0
Annual net profit/ loss1.351,0917,01.023,0864,0187,0
Bilanz in Mio. EURO nach IAS/IFRS20212022202320242025
Aktiva
Summe Umlaufvermögen3.760,03.931,04.508,04.348,04.352,0
Summe Anlagevermögen6.921,07.024,07.550,08.753,08.515,0
Summe Aktiva10.681,010.955,012.058,013.101,012.867,0
Passiva
Summe kurzfristige Verbindlichkeiten2.597,02.512,02.918,02.718,02.390,0
Summe langfristige Verbindlichkeiten9.592,09.335,09.210,09.911,09.725,0
Summe Rückstellungen0,047,076,077,061,0
Summe Eigenkapital-1.508,0-892,0-70,0472,0752,0
Summe Passiva10.681,010.955,012.058,013.101,012.867,0
Management:
Carrie Cox
Helene Gayle
Philip Ozuah
R. Alan B. Ezekowitz
Cynthia Patton
Deborah Leone
Grace Whiteford
Ramona Sequeira
Robert Essner
Rochelle Lazarus
Shalini Sharp
Kevin Ali
Aaron Falcione
Daniel Karp
Joseph Morrissey
Juan Ferreira
Kirke Weaver
Matthew Walsh
Michael Pergine
Nico Van Hoecke
Rachel Stahler
Tom Merriam
Vittorio Nisita
Aufsichtsrat:
Aktionärsstruktur in %:
Adresse: 30 Hudson Street, 33rd floor, 07302 Jersey City
T: +1-551-430-6900
F: +
I: http://www.organon.com
E: